The Association Between Metformin Treatment and Outcomes in Type 2 Diabetes Mellitus Patients With Heart Failure With Preserved Ejection Fraction: A Retrospective Study

Background: Metformin is the first-line antidiabetic medication for type 2 diabetes mellitus (T2DM). However, the association between metformin and outcomes in T2DM patients with heart failure with preserved ejection fraction (HFpEF) is still unknown. We aimed to explore the association between metf...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianfang, Lu, Yi, Min, Xinjia, Yuan, Tan, Wei, Jia, Cai, Zhejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994337/
https://www.ncbi.nlm.nih.gov/pubmed/33778026
http://dx.doi.org/10.3389/fcvm.2021.648212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994337/
https://www.ncbi.nlm.nih.gov/pubmed/33778026
http://dx.doi.org/10.3389/fcvm.2021.648212

Ejemplares similares